Fasting Insulin and HOMA-IR by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis
Measuring Fasting Insulin and HOMA-IR by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis
Lilli Health
500 participants
Feb 1, 2024
OBSERVATIONAL
Conditions
Summary
The study aims to investigate the relationship between fasting insulin and Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) across various demographic factors, including age, sex, race/ethnicity, BMI, and polycystic ovary syndrome (PCOS) diagnosis. By analyzing these variables, the study seeks to identify potential variations in insulin levels, which could provide valuable insights into the impact of different factors on metabolic health and the development of insulin-related conditions.
Eligibility
Inclusion Criteria5
- Age: Participants aged 18+ years.
- Sex: Both males and females.
- Race/Ethnicity: Participants from diverse racial and ethnic backgrounds
- BMI: Participants with a range of body mass index (BMI) values
- PCOS Diagnosis: Participants with and without a confirmed diagnosis PCOS based on established diagnostic criteria.
Exclusion Criteria4
- Age: Participants below 18 years
- Sex: None. Both males and females are included.
- Race/Ethnicity: None. Participants from all racial and ethnic backgrounds are included.
- Endocrine Disorders: Participants with other endocrine disorders affecting insulin levels, such an insulin secreting tumor.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05950282